These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20937779)

  • 1. In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.
    Siswantoro H; Russell B; Ratcliff A; Prasetyorini B; Chalfein F; Marfurt J; Kenangalem E; Wuwung M; Piera KA; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Antimicrob Agents Chemother; 2011 Jan; 55(1):197-202. PubMed ID: 20937779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Clinical Trial Assessing Species-Specific Efficacy of Artemether-Lumefantrine for the Treatment of Plasmodium malariae, Plasmodium ovale, and Mixed Plasmodium Malaria in Gabon.
    Groger M; Veletzky L; Lalremruata A; Cattaneo C; Mischlinger J; Zoleko-Manego R; Endamne L; Klicpera A; Kim J; Nguyen T; Flohr L; Remppis J; Matsiegui PB; Adegnika AA; Agnandji ST; Kremsner PG; Mordmüller B; Mombo-Ngoma G; Ramharter M
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short report: prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar.
    Barnadas C; Ratsimbasoa A; Ranaivosoa H; Ralaizandry D; Raveloariseheno D; Rabekotonorina V; Picot S; Ménard D
    Am J Trop Med Hyg; 2007 Dec; 77(6):1039-42. PubMed ID: 18165518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of a gradual dormancy concept in malaria.
    Richter J; Franken G; Holtfreter MC; Walter S; Labisch A; Mehlhorn H
    Parasitol Res; 2016 Jun; 115(6):2139-48. PubMed ID: 27079460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections.
    Ringwald P; Bickii J; Same-Ekobo A; Basco LK
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2317-9. PubMed ID: 9333075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended clearance time after treatment of infections with Plasmodium malariae may not be indicative of resistance to chloroquine.
    Collins WE; Jeffery GM
    Am J Trop Med Hyg; 2002 Oct; 67(4):406-10. PubMed ID: 12452495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited Polymorphism of the Kelch Propeller Domain in Plasmodium malariae and P. ovale Isolates from Thailand.
    Nakeesathit S; Saralamba N; Pukrittayakamee S; Dondorp A; Nosten F; White NJ; Imwong M
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4055-62. PubMed ID: 27114275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rise and fall of malaria in a West African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study.
    Trape JF; Tall A; Sokhna C; Ly AB; Diagne N; Ndiath O; Mazenot C; Richard V; Badiane A; Dieye-Ba F; Faye J; Ndiaye G; Diene Sarr F; Roucher C; Bouganali C; Bassène H; Touré-Baldé A; Roussilhon C; Perraut R; Spiegel A; Sarthou JL; da Silva LP; Mercereau-Puijalon O; Druilhe P; Rogier C
    Lancet Infect Dis; 2014 Jun; 14(6):476-88. PubMed ID: 24813159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model.
    Robinson LJ; Wampfler R; Betuela I; Karl S; White MT; Li Wai Suen CS; Hofmann NE; Kinboro B; Waltmann A; Brewster J; Lorry L; Tarongka N; Samol L; Silkey M; Bassat Q; Siba PM; Schofield L; Felger I; Mueller I
    PLoS Med; 2015 Oct; 12(10):e1001891. PubMed ID: 26505753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium malariae and Plasmodium ovale infections in the China-Myanmar border area.
    Li P; Zhao Z; Xing H; Li W; Zhu X; Cao Y; Yang Z; Sattabongkot J; Yan G; Fan Q; Cui L
    Malar J; 2016 Nov; 15(1):557. PubMed ID: 27846879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia.
    Maguire JD; Sumawinata IW; Masbar S; Laksana B; Prodjodipuro P; Susanti I; Sismadi P; Mahmud N; Bangs MJ; Baird JK
    Lancet; 2002 Jul; 360(9326):58-60. PubMed ID: 12114045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of Plasmodium malariae and Plasmodium ovale in co-infections with Plasmodium falciparum in asymptomatic malaria parasite carriers in southwestern Nigeria.
    Abdulraheem MA; Ernest M; Ugwuanyi I; Abkallo HM; Nishikawa S; Adeleke M; Orimadegun AE; Culleton R
    Int J Parasitol; 2022 Jan; 52(1):23-33. PubMed ID: 34390743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minor liver profile dysfunctions in Plasmodium vivax, P. malaria and P. ovale patients and normalization after treatment.
    Tangpukdee N; Thanachartwet V; Krudsood S; Luplertlop N; Pornpininworakij K; Chalermrut K; Phokham S; Kano S; Looareesuwan S; Wilairatana P
    Korean J Parasitol; 2006 Dec; 44(4):295-302. PubMed ID: 17170571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria Elimination: Time to Target All Species.
    Lover AA; Baird JK; Gosling R; Price RN
    Am J Trop Med Hyg; 2018 Jul; 99(1):17-23. PubMed ID: 29761762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 20-year longitudinal study of Plasmodium ovale and Plasmodium malariae prevalence and morbidity in a West African population.
    Roucher C; Rogier C; Sokhna C; Tall A; Trape JF
    PLoS One; 2014; 9(2):e87169. PubMed ID: 24520325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of Plasmodium falciparum malaria to amodiaquine, chloroquine and quinine in the Madang Province of Papua New Guinea, 1990-1993.
    al-Yaman F; Genton B; Mokela D; Narara A; Raiko A; Alpers MP
    P N G Med J; 1996 Mar; 39(1):16-22. PubMed ID: 9522846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium malariae Infection Associated with a High Burden of Anemia: A Hospital-Based Surveillance Study.
    Langford S; Douglas NM; Lampah DA; Simpson JA; Kenangalem E; Sugiarto P; Anstey NM; Poespoprodjo JR; Price RN
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004195. PubMed ID: 26720002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.